192 related articles for article (PubMed ID: 32938950)
21. VISTA is an immune checkpoint molecule for human T cells.
Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
[TBL] [Abstract][Full Text] [Related]
22. Discovery and Optimization of Small-Molecule Ligands for V-Domain Ig Suppressor of T-Cell Activation (VISTA).
Gabr MT; Gambhir SS
J Am Chem Soc; 2020 Sep; 142(38):16194-16198. PubMed ID: 32894020
[TBL] [Abstract][Full Text] [Related]
23. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
24. VISTA: Coming of age as a multi-lineage immune checkpoint.
ElTanbouly MA; Schaafsma E; Noelle RJ; Lines JL
Clin Exp Immunol; 2020 May; 200(2):120-130. PubMed ID: 31930484
[TBL] [Abstract][Full Text] [Related]
25. Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA.
Li TT; Jiang JW; Qie CX; Xuan CX; Hu XL; Liu WM; Chen WT; Liu J
BMC Immunol; 2021 Aug; 22(1):55. PubMed ID: 34380434
[TBL] [Abstract][Full Text] [Related]
26. VISTA Regulates the Development of Protective Antitumor Immunity.
Le Mercier I; Chen W; Lines JL; Day M; Li J; Sergent P; Noelle RJ; Wang L
Cancer Res; 2014 Apr; 74(7):1933-44. PubMed ID: 24691994
[TBL] [Abstract][Full Text] [Related]
27. VISTA: A Target to Manage the Innate Cytokine Storm.
ElTanbouly MA; Zhao Y; Schaafsma E; Burns CM; Mabaera R; Cheng C; Noelle RJ
Front Immunol; 2020; 11():595950. PubMed ID: 33643285
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Hou Z; Pan Y; Fei Q; Lin Y; Zhou Y; Liu Y; Guan H; Yu X; Lin X; Lu F; Huang H
J Cancer Res Clin Oncol; 2021 Feb; 147(2):517-531. PubMed ID: 33237432
[TBL] [Abstract][Full Text] [Related]
29. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
[TBL] [Abstract][Full Text] [Related]
30. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
[TBL] [Abstract][Full Text] [Related]
31. The immune checkpoint molecule VISTA regulates allergen-specific Th2-mediated immune responses.
Ohno T; Zhang C; Kondo Y; Kang S; Furusawa E; Tsuchiya K; Miyazaki Y; Azuma M
Int Immunol; 2018 Feb; 30(1):3-11. PubMed ID: 29267882
[TBL] [Abstract][Full Text] [Related]
32. VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.
Prodeus A; Abdul-Wahid A; Sparkes A; Fischer NW; Cydzik M; Chiang N; Alwash M; Ferzoco A; Vacaresse N; Julius M; Gorczysnki RM; Gariépy J
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931757
[TBL] [Abstract][Full Text] [Related]
33. The expression and immunoregulation of immune checkpoint molecule VISTA in autoimmune diseases and cancers.
Wang G; Tai R; Wu Y; Yang S; Wang J; Yu X; Lei L; Shan Z; Li N
Cytokine Growth Factor Rev; 2020 Apr; 52():1-14. PubMed ID: 32057701
[TBL] [Abstract][Full Text] [Related]
34. The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.
Hosseinkhani N; Derakhshani A; Shadbad MA; Argentiero A; Racanelli V; Kazemi T; Mokhtarzadeh A; Brunetti O; Silvestris N; Baradaran B
Front Immunol; 2021; 12():676181. PubMed ID: 34093577
[TBL] [Abstract][Full Text] [Related]
35. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
Huang X; Zhang X; Li E; Zhang G; Wang X; Tang T; Bai X; Liang T
J Hematol Oncol; 2020 Jun; 13(1):83. PubMed ID: 32600443
[TBL] [Abstract][Full Text] [Related]
36. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
Front Immunol; 2020; 11():563044. PubMed ID: 33250890
[TBL] [Abstract][Full Text] [Related]
37. Immunoregulatory functions of VISTA.
Nowak EC; Lines JL; Varn FS; Deng J; Sarde A; Mabaera R; Kuta A; Le Mercier I; Cheng C; Noelle RJ
Immunol Rev; 2017 Mar; 276(1):66-79. PubMed ID: 28258694
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors.
Sun C; He Y; Wang G; Zhang G; Zhang Y; Shen H; Hu L; Sun Y; Jiang B; Wang X; Yuan K; Min W; Wang L; Sun H; Xiao Y; Yang P
J Med Chem; 2024 Mar; 67(5):3590-3605. PubMed ID: 38412237
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models.
Duval KEA; Tavakkoli AD; Kheirollah A; Soderholm HE; Demidenko E; Lines JL; Croteau W; Zhang SC; Wagner RJ; Aulwes E; Noelle RJ; Hoopes PJ
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762046
[TBL] [Abstract][Full Text] [Related]
40. VISTA expressed in tumour cells regulates T cell function.
Mulati K; Hamanishi J; Matsumura N; Chamoto K; Mise N; Abiko K; Baba T; Yamaguchi K; Horikawa N; Murakami R; Taki M; Budiman K; Zeng X; Hosoe Y; Azuma M; Konishi I; Mandai M
Br J Cancer; 2019 Jan; 120(1):115-127. PubMed ID: 30382166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
